{"id":233456,"date":"2025-01-24T16:09:45","date_gmt":"2025-01-24T16:09:45","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=233456"},"modified":"2025-01-24T16:09:45","modified_gmt":"2025-01-24T16:09:45","slug":"obiectivul-meu-de-cariera-este-sa-influentez-pozitiv-cat-mai-multe-vieti","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=233456","title":{"rendered":"\u201eObiectivul meu de carier\u0103 este s\u0103 influen\u0163ez pozitiv c\u00e2t mai multe vie\u0163i\u201d"},"content":{"rendered":"<p>\n<em><strong>&#8230;spune Mihai \u015etefan, Strategy, Innovation &amp; Transformation Head la Novartis Rom\u00e2nia. Ca farmacist \u015fi profesionist \u00een industria farmaceutic\u0103, \u00ee\u015fi dore\u015fte, adaug\u0103 tot el, s\u0103 \u00eembun\u0103t\u0103\u0163easc\u0103 via\u0163a \u015fi s\u0103n\u0103tatea pacien\u0163ilor prin contribu\u0163ia sa constant\u0103.<\/strong><\/em><\/p>\n<p>\nAbsolvent al Facult\u0103\u0163ii de Farmacie din cadrul UMF \u201eCarol Davila\u201d \u015fi al unui EMBA de la Tiffin University, Mihai \u015etefan are peste zece ani de experien\u0163\u0103 \u00een marketing, v\u00e2nz\u0103ri, market access, strategie, inova\u0163ie \u015fi transformare \u00een industria farmaceutic\u0103. \u00cen opinia sa, \u201ecea mai valoroas\u0103 metod\u0103 de \u00eenv\u0103\u0163are este s\u0103 abordezi fiecare moment cu o curiozitate nest\u0103vilit\u0103 \u015fi ascult\u00e2nd activ. \u00cen weekend citesc diverse publica\u0163ii \u015fi ascult podcasturi c\u00e2nd conduc. Aleg c\u00e2teva c\u0103r\u0163i de leadership anual \u015fi particip la traininguri oferite de companie\u201d.<\/p>\n<p>\nNovartis, una dintre cele mai mari companii farmaceutice la nivel interna\u0163ional, are pe pia\u0163a local\u0103 peste 60 de medicamente inovatoare pentru tratamentul bolilor oncologice, cardiovasculare, neurologice \u015fi imunologice. Pia\u0163a farma, \u00een care activeaz\u0103 elve\u0163ienii de la Novartis, a marcat anul acesta un plus de 15%, conform celor mai recente date publicate de Cegedim. Astfel, valoarea medicamentelor eliberate c\u0103tre pacien\u0163i \u00een Rom\u00e2nia \u00een perioada octombrie 2023 \u2013 septembrie 2024 s-a ridicat la 33 miliarde lei (6,6 mld. euro), la pret de distribu\u0163ie, cu 15% mai mult dec\u00e2t \u00een perioada anterioar\u0103 similar\u0103, \u00een timp ce volumul s-a redus cu 1,5%, la un total de 708,3 milioane cutii, arat\u0103 datele Cegedim.<\/p>\n<p>\n<strong>1. Care este obiectivul de carier\u0103 pe care \u00eel ave\u0163i \u00een prezent?<\/strong><\/p>\n<p>\n<img decoding=\"async\" alt=\"\" src=\"http:\/\/storage0.dms.mpinteractiv.ro\/media\/401\/341\/5846\/22654448\/2\/coperta-catalog-100-tineri-managero-de-top.jpg?height=265&amp;width=200\" style=\"width: 200px;height: 265px;margin: 10px;float: left\" \/>Obiectivul meu de carier\u0103 este s\u0103 influen\u0163ez pozitiv c\u00e2t mai multe vie\u0163i, ajut\u00e2nd oamenii s\u0103-\u015fi descopere poten\u0163ialul \u015fi s\u0103-\u015fi dezvolte abilit\u0103\u0163ile pentru un viitor echilibrat \u015fi \u00eemplinit. Ca farmacist \u015fi profesionist \u00een industria farmaceutic\u0103, \u00eemi doresc s\u0103 \u00eembun\u0103t\u0103\u0163esc via\u0163a \u015fi s\u0103n\u0103tatea pacien\u0163ilor prin contribu\u0163ia mea constant\u0103.<\/p>\n<p>\n<strong>2. Care sunt principalele provoc\u0103ri pe care le ave\u0163i \u00een atingerea acestuia \u015fi cum v-a\u0163i propus s\u0103 le dep\u0103\u015fi\u0163i?<\/strong><\/p>\n<p>\nPrincipalele provoc\u0103ri includ rezisten\u0163a la schimbare \u015fi adaptarea rapid\u0103 la noile tehnologii sau reglement\u0103ri. Pentru a le dep\u0103\u015fi, promovez o cultur\u0103 a \u00eenv\u0103\u0163\u0103rii \u015fi inova\u0163iei, oferind mentoring \u015fi sus\u0163inere colegilor mei.<\/p>\n<p>\n<strong>3. Cum v\u0103 gestiona\u0163i timpul \u015fi priorit\u0103\u0163ile \u00eentr-o zi aglomerat\u0103 de lucru? Ave\u0163i vreo metod\u0103 sau rutin\u0103 special\u0103 pentru acest lucru?<\/strong><\/p>\n<p>\nSpre exemplu, \u00eemi prioritizez \u00eent\u00e2lnirile \u00een func\u0163ie de impactul pe care \u00eel pot aduce. Cea mai eficient\u0103 metod\u0103 este s\u0103 spun \u201eNU\u201d \u00eentr-un mod corect \u015fi transparent acolo unde prezen\u0163a mea nu aduce un beneficiu real. Astfel, \u00eemi concentrez energia pe activit\u0103\u0163ile care conteaz\u0103 cu adev\u0103rat.<\/p>\n<p>\n<strong>4. Cum v\u0103 dezvolta\u0163i continuu abilit\u0103\u0163ile de leadership \u015fi management? Participa\u0163i la cursuri de specialitate, seminare, citi\u0163i c\u0103r\u0163i sau ave\u0163i alte modalit\u0103\u0163i?<\/strong><\/p>\n<p>\nCea mai valoroas\u0103 metod\u0103 de \u00eenv\u0103\u0163are este s\u0103 abordezi fiecare moment cu o curiozitate nest\u0103vilit\u0103 \u015fi ascult\u00e2nd activ. \u00cen weekend citesc diverse publica\u0163ii \u015fi ascult podcasturi c\u00e2nd conduc. Aleg c\u00e2teva c\u0103r\u0163i de leadership anual \u015fi particip la traininguri oferite de companie.<\/p>\n<p>\n<strong>5. Munca remote sau de la birou? De ce?<\/strong><\/p>\n<p>\nPrefer un model hibrid: la birou pentru \u00eent\u00e2lniri, brainstorming \u015fi conectare cu colegii \u015fi remote pentru activit\u0103\u0163i ce necesit\u0103 concentrare intens\u0103. La Novartis, suntem sus\u0163inu\u0163i \u00een acest model, ceea ce ne permite s\u0103 fim productivi \u015fi echilibra\u0163i.<\/p>\n<p>\n<strong>6.&nbsp; Care sunt calit\u0103\u0163ile pe care le aprecia\u0163i cel mai mult la colegii din echipele pe care le coordona\u0163i? Dar defectele pe care nu le pute\u0163i tolera?<\/strong><\/p>\n<p>\nApreciez onestitatea \u015fi colaborarea: aceste calit\u0103\u0163i construiesc \u00eencredere \u015fi echipe puternice. Nu tolerez atitudinea negativ\u0103 \u015fi lipsa de responsabilitate, deoarece acestea pot distruge moralul \u015fi productivitatea.<\/p>\n<p>\n<strong>7. Exist\u0103 work-life balance \u00een prezent? (detalii personalizate despre felul \u00een care v\u0103 raporta\u0163i la acesta)?<\/strong><\/p>\n<p>\nExist\u0103 work-life balance atunci c\u00e2nd scopul t\u0103u, at\u00e2t la nivel personal, c\u00e2t \u015fi profesional, este s\u0103 generezi impact \u015fi e\u015fti sincer cu tine \u00eensu\u0163i \u00een gestionarea timpului personal. Adesea d\u0103m vina pe context sau pe ceilal\u0163i, \u00een loc s\u0103 recunoa\u015ftem c\u0103 alegem autopilotul. La Novartis, suntem noroco\u015fi c\u0103 suntem \u00eencuraja\u0163i s\u0103 nu uitam de echilibrul vie\u0163ii noastre.<\/p>\n<p>\n<strong>8. Cine este mentorul\/persoana care v\u0103 inspir\u0103 \u00een carier\u0103?<\/strong><\/p>\n<p>\nFiica mea m\u0103 inspir\u0103 \u00een fiecare zi s\u0103 redescop\u0103r lumea prin ochii unui copil. De la ea \u00eenv\u0103\u0163 s\u0103 fiu deschis, curios \u015fi s\u0103 apreciez micile bucurii ale vie\u0163ii. Aceast\u0103 perspectiv\u0103 \u00eemi \u00eembog\u0103\u0163e\u015fte at\u00e2t cariera, c\u00e2t \u015fi via\u0163a privat\u0103.<\/p>\n<p>\n<strong>9. Ce hobby-uri ave\u0163i \u015fi care sunt \u00eenv\u0103\u0163\u0103turile de carier\u0103 desprinse din acestea?<\/strong><\/p>\n<p>\nC\u0103l\u0103toriile \u015fi lectura. C\u0103l\u0103toriile m\u0103 \u00eenva\u0163\u0103 s\u0103 apreciez diversitatea \u015fi s\u0103 fiu adaptabil, iar lectura \u00eemi dezvolt\u0103 perspectivele \u015fi g\u00e2ndirea critic\u0103. Ambele m\u0103 ajut\u0103 s\u0103 fiu mai bun \u00een via\u0163a profesional\u0103 \u015fi personal\u0103.<\/p>\n<p>\n<strong>10.&nbsp; Mai este loc de lectur\u0103 \u00een agenda unui lider al prezentului? Ce citi\u0163i \u015fi care sunt titlurile preferate?<\/strong><\/p>\n<p>\nLectura este pentru mine un ingredient vital pentru o via\u0163\u0103 echilibrat\u0103. Citesc SF \u015fi fantezie pentru deconectare \u015fi istorie, economie, filosofie \u015fi biografii pentru a \u00een\u0163elege un context mai larg. Acum citesc \u201eThe Code Breaker\u201d de Walter Isaacson, esen\u0163ial\u0103 pentru a \u00een\u0163elege provoc\u0103rile din cercetarea medical\u0103 de avangard\u0103 \u015fi impactul asupra umanit\u0103\u0163ii.&nbsp;&nbsp;<\/p>\n<hr \/>\n<p>\n<strong>Mihai \u015etefan, Strategy, Innovation &amp; Transformation Head, Novartis Rom\u00e2nia<\/strong><\/p>\n<p>\n<strong>V\u00e2rst\u0103: 35 ani<\/strong><\/p>\n<p>\n<strong><span style=\"color:#3399ff\">Cifr\u0103 de afaceri (2022): 997 mil lei<\/span><\/strong><\/p>\n<p>\n<strong><span style=\"color:#3399ff\">Profit net (2022):&nbsp;<\/span><\/strong><\/p>\n<p>\n<strong><span style=\"color:#3399ff\">30,3 mil. lei<\/span><\/strong><\/p>\n<p>\n<strong><span style=\"color:#3399ff\">Nr. de angaja\u0163i: &gt; 550<\/span><\/strong><\/p>\n<p>\n&nbsp;<\/p>\n<hr \/>\n<p>\n<strong>BUSINESS Magazin a lansat \u015fi anul trecut catalogul 100 TINERI MANAGERI DE TOP. <span style=\"color:#3399ff\">Sub umbrela \u201eRising Stars: Cum schimb\u0103 liderii din noile genera\u0163ii businessul rom\u00e2nesc?\u201d, cea mai recent\u0103 edi\u0163ie a catalogului \u00ee\u015fi propune s\u0103 releve faptul c\u0103 liderii de afaceri din noile genera\u0163ii sunt la fel de dornici s\u0103 genereze profituri ca \u015fi genera\u0163iile anterioare, dar nu cu orice pre\u0163, fiind primii executivi care fac trecerea spre o libertate \u015fi o relaxare asumate. Mihai \u015etefan, strategy, innovation &amp; transformation head, Novartis Rom\u00e2nia, se num\u0103r\u0103 printre cei 100 de tineri manageri pe care BM \u00eei include \u00een aceast\u0103 edi\u0163ie a catalogului.<\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8230;spune Mihai \u015etefan, Strategy, Innovation &amp; Transformation Head la Novartis Rom\u00e2nia. Ca farmacist \u015fi profesionist \u00een industria farmaceutic\u0103, \u00ee\u015fi dore\u015fte, adaug\u0103 tot el, s\u0103 \u00eembun\u0103t\u0103\u0163easc\u0103 via\u0163a \u015fi s\u0103n\u0103tatea pacien\u0163ilor prin contribu\u0163ia sa constant\u0103. Absolvent al Facult\u0103\u0163ii de Farmacie din cadrul UMF \u201eCarol Davila\u201d \u015fi al unui EMBA de la Tiffin University, Mihai \u015etefan are peste [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[511,512],"tags":[234,32515,10579],"class_list":["post-233456","post","type-post","status-publish","format-standard","hentry","category-afaceri","category-revista-bm","tag-leadership","tag-mihai-stefan","tag-novartis"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/233456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=233456"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/233456\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=233456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=233456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=233456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}